CD

Carl Decicco

Pharmaceutical Executive

New Hope, Pennsylvania

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $500,000.00

  • Max Investment:

    $15,000,000.00

  • Target Investment:

    $7,000,000.00

Skills

Medicinal Chemistry
Drug Discovery
Organic Chemistry
Drug Development
Pharmaceutical Industry
Drug Design
Clinical Development
Chemistry
Biotechnology
Oncology
Technology Transfer
CRO
Lifesciences
Analytical Chemistry
Lead Change
Organic Synthesis
Pharmacology
Translational Medicine
Parallel Synthesis
R&D

Education

Lists including Carl

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

FP
Flagship Pioneering

2018

  • Partner

    2018

FT
Foghorn Therapeutics, Inc

2018 - 2022

  • Chief Scientific Officer

    2018 - 2022

BS
Bristol-Myers Squibb

2013 - 2018

  • Senior Vice President, Head of Discovery

    2013 - 2018

BS
Bristol-Myers Squibb

2002 - 2013

  • Senior Vice President, Molecular Sciences

    2010 - 2013

  • Vice President, Discovery Chemistry/Molecular Sciences

    2002 - 2010